[D-Arg1, D-Phe5, D-Trp7,9, Leu11]substance P inhibits the growth of human small cell lung cancer xenografts in vivo
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10), 1450-1453
- https://doi.org/10.1016/0959-8049(93)90019-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidusNature, 1992
- The binding of endogenous and exogenous substance-P in human plasmaBiochemical Pharmacology, 1990
- Bradykinin receptors: Characterization, distribution and mechanisms of signal transductionProgress in Growth Factor Research, 1989
- Metabolism of protein anticancer agentsPharmacology & Therapeutics, 1987
- cDNA eloping of bovine substance-K receptor through oocyte expression systemNature, 1987
- Tachykinin antagonists have potent local anaesthetic actionsEuropean Journal of Pharmacology, 1985
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- The antagonism of bombesin in the CNS by substance P analoguesLife Sciences, 1984
- Sensory and Motor Functions of Spinal Cord Substance PScience, 1981
- Analgesic effect of antagonists of substance PBiochemical and Biophysical Research Communications, 1981